SC 13G/A: MAXCYTE, INC.

AI Summary

SC 13G/A filing by MAXCYTE, INC..

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.01 — ame of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securitie

Filing Documents

• form_sc13ga-maxcyte.htm (SC 13G/A) — 161KB
• 0001011438-24-000634.txt ( ) — 163KB

From the Filing

SC 13G/A 1 form_sc13ga-maxcyte.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* MaxCyte, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 57777K106 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [_] Rule 13d-1(c) [_] Rule 13d-1(d) __________ *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 57777K106 1. NAME OF REPORTING PERSONS Cadian Capital Management, LP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [_] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 8,188,948 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 8,188,948 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 8,188,948 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.8% (1) 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IA, PN (1) Based on 105,482,558 shares of Common Stock of MaxCyte, Inc. (the "Issuer") outstanding as of November 1, 2024, as disclosed in the Issuer's Form 10-Q filed with the Securities and Exchange Commission ("SEC") on November 6, 2024. CUSIP No. 57777K106 1. NAME OF REPORTING PERSONS Cadian Capital Management GP, LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [_] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 8,188,948 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 8,188,948 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 8,188,948 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.8% (1) 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO, HC (1) Based on 105,482,558 shares of Common Stock of the Issuer outstanding as of November 1, 2024, as disclosed in the Issuer's Form 10-Q filed with the SEC on November 6, 2024. CUSIP No. 57777K106 1. NAME OF REPORTING PERSONS Eric Bannasch 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [_] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION United States of America NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 8,188,948 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 8,188,948 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 8,188,948 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.8% (1) 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN, HC (1) Based on 105,482,558 shares of Common Stock of the Issuer outstanding as of November 1, 2024, as disclosed in the Issuer's Form 10-Q filed with the SEC on November 6, 2024. CUSIP No. 57777K106 Item 1. (a). Name of Issuer: MaxCyte, Inc. (the "Issuer") (b). Address of Issuer's Principal Executive Offices: 9713 Key West Avenue, Suite 400 Rockville, Maryland 20850 Item 2. (a). Name of Person Filing: Cadian Capital Management, LP Cadian Capital Management GP, LLC Eric Bannasch The filing persons named above are collectively referred to herein as the "Reporting Persons." (b). Address of Principal Business Office, or if None, Residence: Cadian Capital Management, LP 535 Madison Avenue 36th Floor New York, NY 10022 Cadian Capital Management GP, LLC 535 Madison Avenue 36th Floor New York, NY 10022 Eric Bannasch 535 Madison Avenue 36th Floor New York, NY 10022 (c). Citizenship: Cadian Capital Management, LP – Delaware Cadian Capital Management GP, LLC – Delaware Eric Bannasch – United States of America (d). Title of Class of Securities: Common Stock, par value $0.01 per share ("Common Stock") (e). CUSIP No.: 57777K106 Item 3. If This Statement

View Full Filing

View this SC 13G/A filing on SEC EDGAR